UBS AM
PRAH

UBS AM’s PRA Health Sciences, Inc. PRAH Stock Holding History

UBS AM’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-99,360
Closed -$15.2M – 2796
2021
Q1 		$15.2M Sell
99,360
-2,992
-3% -$406K 0.01% 945
2020
Q4 		$12.8M Buy
102,352
+13,953
+16% +$1.56M 0.01% 966
2020
Q3 		$8.97M Buy
88,399
+6,672
+8% +$680K ﹤0.01% 971
2020
Q2 		$7.95M Sell
81,727
-662
-0.8% -$61.6K ﹤0.01% 977
2020
Q1 		$6.84M Buy
82,389
+7,649
+10% +$746K ﹤0.01% 965
2019
Q4 		$8.31M Buy
74,740
+4,507
+6% +$464K 0.01% 1007
2019
Q3 		$6.97M Buy
70,233
+6,958
+11% +$691K ﹤0.01% 1080
2019
Q2 		$6.27M Buy
63,275
+5,860
+10% +$559K ﹤0.01% 1115
2019
Q1 		$6.33M Buy
57,415
+12,279
+27% +$1.28M ﹤0.01% 1069
2018
Q4 		$4.15M Buy
45,136
+2,675
+6% +$271K ﹤0.01% 1153
2018
Q3 		$4.68M Buy
42,461
+4,112
+11% +$428K ﹤0.01% 1159
2018
Q2 		$3.58M Buy
38,349
+8,049
+27% +$693K ﹤0.01% 1275
2018
Q1 		$2.51M Buy
30,300
+2,270
+8% +$202K ﹤0.01% 1376
2017
Q4 		$2.55M Buy
28,030
+293
+1% +$24.4K ﹤0.01% 1327
2017
Q3 		$2.11M Buy
27,737
+5,679
+26% +$429K ﹤0.01% 1382
2017
Q2 		$1.65M Buy
22,058
+1,303
+6% +$90.3K ﹤0.01% 1433
2017
Q1 		$1.35M Buy
20,755
+7,999
+63% +$471K ﹤0.01% 1510
2016
Q4 		$703K Sell
12,756
-4,885
-28% -$268K ﹤0.01% 1700
2016
Q3 		$996K Buy
17,641
+4,407
+33% +$216K ﹤0.01% 1693
2016
Q2 		$553K Buy
13,234
+1,400
+12% +$64.5K ﹤0.01% 1912
2016
Q1 		$506K Buy
11,834
+4,540
+62% +$192K ﹤0.01% 1914
2015
Q4 		$330K Hold
7,294
– – ﹤0.01% 2296
2015
Q3 		$283K Buy
7,294
+494
+7% +$19.8K ﹤0.01% 2317
2015
Q2 		$247K Buy
+6,800
New +$215K ﹤0.01% 2484

Other funds holding PRAH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

UBS AM's PRAH Position: Q2 2021 in Review

UBS AM sold out of PRA Health Sciences, Inc. (PRAH) in Q2 2021, closing a stake of 99,360 shares — an estimated $15.2M sold.

UBS AM first reported a position in PRAH in Q2 2015 and held it in 24 quarters. The position peaked at $15.2M in Q1 2021. 317 funds tracked by Wall St. Rank hold PRAH as of Q2 2021.

  • UBS AM reported no remaining PRA Health Sciences, Inc. position as of Q2 2021 after selling out during the quarter.
  • UBS AM sold 99,360 PRA Health Sciences, Inc. shares in Q2 2021, an estimated $15.2M.
  • UBS AM first reported a position in PRA Health Sciences, Inc. in Q2 2015 and held it in 24 quarters.
  • UBS AM's PRA Health Sciences, Inc. position peaked at $15.2M in Q1 2021.
  • 317 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q2 2021.

Based on UBS AM's 13F filing for Q2 2021, filed 16 Aug 2021.